ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,898Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1111

$1.2M Total Retail Price of All Prescriptions

Rank: 27 out of 1111

542 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 13,647 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 726 551 1 2
FUROSEMIDE 651 518 2 6
TRAMADOL HCL 651 395 2 13
OMEPRAZOLE 579 437 4 4
LEVOTHYROXINE SODIUM 481 427 5 3
CITALOPRAM HBR 383 292 6 14
MELOXICAM 370 250 7 18
AMLODIPINE BESYLATE 349 247 8 7
SIMVASTATIN 331 253 9 5
METOPROLOL TARTRATE 322 241 10 12
POTASSIUM CHLORIDE 292 239 11 9
HYDROCODONE-ACETAMINOPHEN 291 216 S3 12 1
ZOLPIDEM TARTRATE 270 160 13 16
WARFARIN SODIUM 264 229 14 19
GABAPENTIN 263 162 15 10
DONEPEZIL HCL 258 228 16 25
METFORMIN HCL 256 159 17 8
RISPERIDONE 235 198 18 60
KLOR-CON M20 235 192 18 79
RANITIDINE HCL 234 202 20 29
NAMENDA 230 223 21 31
POLYETHYLENE GLYCOL 3350 209 167 22 45
TAMSULOSIN HCL 189 152 23 28
PRAVASTATIN SODIUM 163 124 24 17
CLONIDINE HCL 162 116 25 42
METOPROLOL SUCCINATE 158 128 26 20
MEGESTROL ACETATE 155 136 R 27 103
LANTUS 153 97 28 46
DIGOXIN 148 140 29 47
CARVEDILOL 147 103 30 21
SERTRALINE HCL 141 75 31 24
ATORVASTATIN CALCIUM 141 104 31 15
JANUVIA 134 102 33 75
HYDRALAZINE HCL 132 79 34 155
CYMBALTA 131 73 35 40
GLIPIZIDE 126 101 36 57
EVISTA 125 108 37 148
TRAMADOL HCL-ACETAMINOPHEN 119 50 38 214
ESCITALOPRAM OXALATE 119 80 38 78
MIRTAZAPINE 119 82 38 52
ADVAIR DISKUS 117 98 41 43
NEXIUM 117 79 41 26
CLOPIDOGREL 112 92 43 30
NYSTOP 111 97 44 175
ALBUTEROL SULFATE 105 75 45 136
ROPINIROLE HCL 105 75 45 68
HYDROCHLOROTHIAZIDE 104 65 47 11
PAROXETINE HCL 102 54 48 55
FENTANYL 100 66 S2 49 65
PROAIR HFA 96 42 50 38
FLUTICASONE PROPIONATE 95 65 51 27
NOVOLIN R 94 74 52 142
FLUOXETINE HCL 90 62 53 44
AMITIZA 89 70 54 366
PLAVIX 88 64 55 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 70 56 71
CYCLOBENZAPRINE HCL 86 53 R 56 37
OXYBUTYNIN CHLORIDE ER 85 83 58 114
PROMETHAZINE HCL 85 48 R 58 69
CARBIDOPA-LEVODOPA 84 82 60 101
DIVALPROEX SODIUM 83 60 61 82
DIOVAN 82 60 62 51
AMLODIPINE BESYLATE-BENAZEPRIL 81 52 63 67
LEVOFLOXACIN 81 53 63 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 52 65 23
TRAZODONE HCL 77 47 66 32
ACTOS 76 53 67 98
PHENYTOIN SODIUM EXTENDED 76 23 67 126
ALLOPURINOL 75 62 69 36
SPIRONOLACTONE 71 40 70 83
METOLAZONE 69 24 71 162
ATENOLOL 69 38 71 22
PATANOL 65 35 73 312
QUETIAPINE FUMARATE 63 50 74 76
NAPROXEN 62 51 75 85
LYRICA 62 51 75 62
SPIRIVA 62 58 75 53
VENLAFAXINE HCL ER 60 31 78 105
AMITRIPTYLINE HCL 60 28 R 78 64
SINGULAIR 59 46 80 112
PANTOPRAZOLE SODIUM 59 51 80 50
PREDNISONE 58 29 82 48
TRAVATAN Z 58 53 82 183
LEVETIRACETAM 57 32 84 111
CARBAMAZEPINE 55 28 85 196
NOVOLOG 54 29 86 104
ENOXAPARIN SODIUM 54 53 86 228
LOSARTAN POTASSIUM 53 38 88 34
DETROL LA 52 34 89 139
PHENYTOIN 52 28 89 272
SYMBICORT 51 38 91 176
KLOR-CON M10 51 45 91 144
EXELON 51 46 91 121
CIPROFLOXACIN HCL 50 36 94 58
NYSTATIN 50 46 94 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.